Neo-Sensitabs Susceptibility Testing

Similar documents
EUCAST recommended strains for internal quality control

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

European Committee on Antimicrobial Susceptibility Testing

EUCAST-and CLSI potency NEO-SENSITABS

European Committee on Antimicrobial Susceptibility Testing

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

What s new in EUCAST methods?

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

AMR Industry Alliance Antibiotic Discharge Targets

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Product Catalogue 2017 Clinical and Industrial Microbiology

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

2015 Antibiotic Susceptibility Report

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Intrinsic, implied and default resistance

Product Catalogue 2016 Clinical and Industrial Microbiology

2016 Antibiotic Susceptibility Report

EUCAST-and CLSI potency NEO-SENSITABS Main index

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Antimicrobial Susceptibility Testing: Advanced Course

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1

Antimicrobial Susceptibility Testing: The Basics

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

Performance Information. Vet use only

MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

ESCMID Online Lecture Library. by author

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

56 Clinical and Laboratory Standards Institute. All rights reserved.

ESCMID Online Lecture Library. by author

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

British Society for Antimicrobial Chemotherapy

Mechanism of antibiotic resistance

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

CONTAGIOUS COMMENTS Department of Epidemiology

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

British Society for Antimicrobial Chemotherapy

Antimicrobial susceptibility

Antimicrobial Resistance Strains

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Main objectives of the EURL EQAS s

Concise Antibiogram Toolkit Background

EARS Net Report, Quarter

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

2 New products for 2014

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

HUSRES Annual Report 2007 Martti Vaara.

CONTAGIOUS COMMENTS Department of Epidemiology

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

BSAC standardized disc susceptibility testing method (version 8)

Background and Plan of Analysis

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Version 1.01 (01/10/2016)

CONTAGIOUS COMMENTS Department of Epidemiology

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Antimicrobial Susceptibility Patterns

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Understanding the Hospital Antibiogram

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Quality assurance of antimicrobial susceptibility testing

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

RCH antibiotic susceptibility data

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Mongolia September 2012

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Available online at ISSN No:

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

APPENDIX III - DOUBLE DISK TEST FOR ESBL

This document is protected by international copyright laws.

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

Transcription:

Neo-Sensitabs Susceptibility Testing Potencies according to EUCAST and CLSI Product list 2014 Unique characteristics ensure that NEO-SENSITABS are ideal for use in the laboratory Susceptibility testing with NEO-SENSITABS practice is performed according CLSI and EUCAST guidelines. Rosco Diagnostica is the leader in the field of phenotypic methods for detection of 12-02-2014 Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

Neo-Sensitabs - Products in Alphabetical Order Packaging Neo-Sensitabs are packed in cartridges containing 1 x tablets Minimum sale: 1 package containing 5 cartridges (2 tablets) Please order per package on your order sheets REF No. Antibiotic Code A Potency µg 2-8 EUCAST CLSI 60012 Amikacin AMI30 30 x x 70112N Amoxycillin AMOXY 30 x 69812 Amoxycillin + Clavulanate AMC.3 2+1 n x 60112 Amoxycillin + Clavulanate AMC30 20+10 n x x 66712 Ampicillin AMP.2 2 x 60212 Ampicillin AMP10 10 x x 63412 Ampicillin + Sulbactam SAM20 10+10 x 60312 Azithromycin AZI15 15 x x 63612 Aztreonam AZT30 30 x x B 70812N Bacitracin BACIT 40 C 612 Cefaclor CCL30 30 x x 60412 Cefazolin CFZ30 30 x 63712 Cefepime FEP30 30 n x x 64812 Cefepime + Clavulanate FEP+C 30+10 n 63312 Cefixime CFM.5 5 x x 89312 Ceftolozane + Tazobactam C / T 30 + 10 x 65812 Cefotaxime CTX05 5 x 63912 Cefotaxime CTX30 30 x 64712 Cefotaxime + Clavulanate CTX+C 30+10 n 66612 Cefotaxime + Boronic Acid CTXBO 30 66512 Ceftazidime + Boronic Acid CAZBO 30 80612N Cefoxitin CFCID 10 62912 Cefoxitin CFO30 30 x x 63212 Cefpodoxime CPD10 10 n x x 80912 Cefpodoxime + Clavulanate CPD+C 10+1 n 69312 Ceftaroline CPT30 30 x 89012 Ceftaroline CPT. 5 5 x 66012 Ceftazidime CAZ10 10 x 64012 Ceftazidime CAZ30 30 x 64612 Ceftazidime + Clavulanate CZ+CL 30+10 n 68412 Ceftibuten CBT30 30 x 64112 Ceftizoxime ZOX30 30 x 67212 Ceftobiprole CFBIP 30 n x 64212 Ceftriaxone CTR30 30 x x 60512 Cefuroxime CXM30 30 x x 72812N Cephalexin CFLEX 30 x 60612 Cephalothin CEP30 30 x 73012N Cephradine CFRAD 60 x 60712 Chloramphenicol CLR30 30 x x 65312 Ciprofloxacin CIPR1 1 60812 Ciprofloxacin CIRP5 5 x x 60912 Clarithromycin CLA15 15 x x 62512 Clindamycin CLI.2 2 x x 66312 Colistin CO.10 10 x x D 80312N Daptomycin DAPCa 30 (+100) 63012 Doxycycline DOX30 30 x x 66212 Doripenem DOR10 10 x x 12-02-2014 Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

REF No. Antibiotic Code E Potency µg 2-8 EUCAST CLSI 80712 Ertapenem ETP10 10 n x x 61012 Erythromycin ERY15 15 x x F 62312 Fosfomycin FO200 200 n x 67712 Fucidin FUC10 10 x x 74312N Fucidin FUCID 100 x 74412N Furazolidone FURAZ x G 61112 Gentamicin GEN10 10 x x 69512 Gentamicin GEN30 30 x 43012N Gentamicin GN2 2 x x I 61212 Imipenem IMI10 10 x x 66412 Imipenem + EDTA IM10E 10 + 7 K 62412 Kanamycin KAN30 30 x 43112N Kanamycin KA0 0 x L 74812N Levofloxacin LEVOF 5 x x 67812 Linezolid LIZ10 10 x 75112N Linezolid LINEZ 30 x M 61312 Mecillinam MEC10 10 x x 64312 Meropenem MRP10 10 x x 59711 Metronidazole MTR.5 5 x x 75512N Metronidazole MTR16 16 63112 Minocycline MIN30 30 x x 79812N Moxifloxacin MOXIF 5 x x 75712N Mupirocin MUPIR 10 69212 Mupirocin MP200 200 x x N 61412 Nalidixan NAL30 30 x x 75912N Neomycin NEOMY 120 69412 Netilmicin NET10 10 x 61512 Netilmicin NET30 30 x 67012 Nitrofurantoin NI100 100 x 65712 Nitrofurantoin NI200 200 62612 Nitrofurantoin NI300 300 x 76212N Norfloxacin NORFX 10 x x 76312N Novobiocin NOVO5 5 x O 61612 Ofloxacin OFL.5 5 x x 68312 Oxacillin OXA.1 1 x x P 76912N Pefloxacin (stop production) PEFLX 10 x 77012N Pefloxacin PEF.5 5 x 66912 Penicillin (Penicillin G) PENG1 1 x x 61712 Penicillin (Penicillin G) PEN10 10 x 77212N Pipemicid Acid PIPEM 30 x 68112 Piperacillin PIP30 30 x 77312N Piperacillin PIPRA 100 x 66812 Piperacillin + Tazobactam PTZ36 30 + 6 x 77412N Piperacillin + Tazobactam PI+TZ 100 + 10 x 77512N Polymyxins (Colistin) CO1 1 Q 80012N Quinupristin - Dalfopristin SYN15 15 x x 12-02-2014 Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

REF No. Antibiotic Code R 67312 Retapamulin RETA.2 2 Potency µg 2-8 EUCAST CLSI 62712 Rifampicin RIF.5 5 x x S 77812N Spectinomycin SPECT 200 x 61812 Streptomycin STR10 10 x 44712N Streptomycin ST0 0 x 78112N Sulphonamides SULFA 240 x T 61912 Teicoplanin TPN30 30 x x 80112N Telithromycin TEL15 15 x x 78312N Temocillin TEMOC 30 n x x 62012 Tetracyclines (Oxytetracycline) TET30 30 x x 64912 Ticarcillin TIC75 75 n x x 64412 Ticarcillin + Clavulanate TIM85 75 + 10 n x x 80412N Tigecycline TIG15 15 x x 62112 Tobramycin TOB10 10 x x 64512 Trimethoprim TRIM5 5 x x 62212 Trimethoprim + Sulfamethoxazole SxT25 1.25 + 23.7 x x 65512 Trimethoprim 2,5 V 68812 Vancomycin VAN.5 5 x 62812 Vancomycin VAN30 30 x n= Store at 2 8 C Our product have 2 years to 5 years of expire date. For more product information When cartridges are opened and placed in a dispenser: Cartridges to be kept at room temperature: To be used within the next 12 months. ncartridges to be kept at 2-8 degrees: To be used within 2 months. Accessories REF No. 97105 Product Dispenser 1 cartridge single dispenser 97109 Dispenser 7 cartridges round Petri dishes of 9 cm diameter 97112 Dispenser 12 cartridges round Petri dishes of 14-15 cm diameter 97104 Dispenser 16 cartridges square Petri dishes of 12 x 12 cm 93402 ID Plate - Zone readings 901 Zone Measuring stick 12-02-2014 Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

Diatabs Identification of Bacteria and Fungi Product list 2014 01-01-2014 Diatabs TM Rosco Diagnostica A/S Product list

Diatabs - Products in Alphabetical Order REF Tablets Product Diatabs 2-8 Code No. per vial A Tablet in mm 52011 Adonitol ADO 6 55921 Alkaline Phosphatase n Alk P 25 6 211 Alpha-Galactosidase α-gal 6 411 Alpha-Glucosidase α-glu 6 52121 l-arabinose n ARA 25 6 56211 Arginine Dihydrolase ADH 6 B 40211 Bacitracin Low 0.4 U BaL 6** 511 Beta-Glucosidase β-glu 6 611 Beta-Glucuronidase PGUA 6 45521 Beta-Lactamase n ACIDO 25 6 821 Beta-Xylosidase β-xyl 25 6 40411 Bile Esculin BE 6 10041 Boronic Acid BORON 25 9** 40511 Brilliant Green 100 µg BrG 6** C 41621 C-390 40 µg C-390 25 9* 10031 Cloxacillin n CLOXA 25 9** 58911 Cycloheximide CYC 9** D 59611 Deferoxamine 2 µg DEFRX 9** 10051 Dipicolinic Acid D.P.A. 25 9** 54021 d-xylose n XYL 25 6 E 56611 Esculin Hydrolysis ESC 6 F 42611 Factor V n 6** 42511 Factor X n 6** 42711 Factor X + V n 6** G 46711 Gamma-Glutamyl Aminopeptidase g-glu 6 52611 Glucose GLU 6 H 56711 Hippurate Hydrolysis HIP 6 I 591 Indoxyl Acetate n IAC 10 6 52711 Inulin INU 6 L 52811 Lactose LAC 6 58411 LDC/Indole (Lysine Decarboxylase/Indole) LDC/IND 6 46811 Leucine Aminopeptidase LAP 6 56811 Lysine Decarboxylase LDC 6 01-01-2014 Diatabs TM Rosco Diagnostica A/S Product list

REF Tablets Product Diatabs 2-8 Code No. per vial M Tablet in mm 52911 Maltose MAL 6 53011 Mannitol MAN 6 53111 Mannose MSE 6 59711 Metronidazole 5 µg MTR.5 9** 43611 Metronidazole µg MTR 9** N 43711 Nitrate Reduction NO3 6 O 45421 O/129 (Vibriostaticum) 1 µg O/129 25 9** 311 ONPG (Beta-Galactosidase) ONPG 6 44211 Optochin 10 µg OPT 6** 57011 Ornithine Decarboxylase ODC 6 44311 Oxgall 1000 µg OXG 6** 45711 Oxidase OXI 6 P 59011 PGUA/Indole (Beta-Glucuronidase/Indole) PGUA/IND 6 57321 Porphyrin (d-ala) ALA 25 6 46911 Proline Aminopeptidase n PRO 6 59311 Ps. aeruginosa Screen 80 µg PSAER 9** 59811 Pyrazinamidase PZA 6 47011 Pyrrolidonyl Aminopeptidase PYR 6 R 53411 l-rhamnose RHAM 6 S 44611 S.P.S. 1000 µg SPS 6** 53711 Sorbitol SOR 6 53811 Sucrose SUC 6 T 57811 TDA or Indole (Tryptophan Deaminase or Indole) TDA or IND 6 411 Tellur 0 µg TEL 6** 53911 Trehalose TRE 6 48821 Tributyrin n TRIB 25 6 47211 Trypsin TRYP 6 U 57511 Urease URE 6 57611 Urease/Indole URE/IND 6 57911 Urease/TDA URE/TDA 6 V 57711 Voges-Proskauer VP 6 n = Store at 2 8 C ** Diatabs tablets to be used on agar media for more information: (Diatabs User s Guide) 01-01-2014 Diatabs TM Rosco Diagnostica A/S Product list

Reagents REF NO Product Reagents Stored at 2 8 C ML per sales Unit 91731 Ninhydrin 3,5% solution n 20 ml 92031 Kovac s Reagent n 20 ml 92231 Aminopeptidase reagent n 20 ml 91831 N-N-Dimethyl-a-naphtyl. n 20 ml 91931 Sulfalinic Acid n 20 ml CE Marking All products are CE marked according to the European Directive 98/79/EC for In Vitro Diagnostic Medical Devices. Instructions For Use The relevant Instructions for use of each product are made freely available on our Website: in 7 12 different European languages. Diatabs User s Guide The latest version of the Diatabs User s Guide is downloadable from our website. 01-01-2014 Diatabs TM Rosco Diagnostica A/S Product list

Neo-Sensitabs Antifungal Agents Product list 2014 Unique characteristics ensure that NEO-SENSITABS are ideal for use in the clinic Susceptibility testing with NEO-SENSITABS practice is performed according CLSI and EUCAST guidelines. Rosco Diagnostica is the leader in the field of phenotypic methods for detection of 01-01-2014 Neo-Sensitabs Antifungal Agents Rosco Diagnostica A/S Product list 2014

Neo-Sensitabs Antifungal Agents- Products in Alphabetical Order Packaging Neo-Sensitabs Antifungals are packed in cartridges containing 1 x tablets Minimum sale: 1 package containing 5 cartridges (2 tablets) Please order per package on order sheets REF No. Product Code Potency 2-8 81012N Amphotericin B AMPHO 10 n 82412N Caspofungin CASP5 5 n 81112N Ciclopirox CICLO 81212N Clotrimazole CTRIM 10 81312N Econazole ECONZ 10 82512N Fluconazole FLUCZ 25 81512N Fluorocytosine FLU.1 1 81812N Itraconazole ITRAC 10 81912N Ketoconazole KETOC 15 82012N Miconazole MICOZ 10 82212N Nystatin NYSTA 82612N Posaconazole POSAC 5 87412N Terbinafine TERBI 30 82312N Voriconazole VOR.1 1 n = Store at 2 8 C Instructions for Use Neo-Sensitabs The Instructions for Use are made freely available on our web site It can be downloaded in PDF format in different European languages. CE Marking All products - except the Veterinary Antimicrobials - are CE marked according to The European Directive 98 /79/ EC for In Vitro Diagnostic Medical Devices. For more product information go to Rosco website 01-01-2014 Neo-Sensitabs Antifungal Agents Rosco Diagnostica A/S Product list 2014

Kits for Detection of Resistance Mechanisms Product list 2014 Unique characteristics ensure that NEO-SENSITABS are ideal for use in the laboratory Susceptibility testing with NEO-SENSITABS practice is performed according CLSI and EUCAST guidelines. Minimum orders for kits are 1 package. Rosco Diagnostica is the leader in the field of phenotypic methods for detection of 12-02-2014 Kits Product list Rosco Diagnostica A/S

Screening and Confirmation of ESBL s REF no. Product Tests pr. kit Detection of: Total ESBL Confirm Kit (EUCAST) 98014 Cefotaxime Cefotaxime + Clavulanate Ceftazidime Ceftazidime + Clavulanate Cefepime Cefepime + Clavulanate ESBL ESBL Confirm (acc. to CLSI) Kit 98011 Cefotaxime Cefotaxime + Clavulanate Ceftazidime Ceftazidime + Clavulanate ESBL 98012 ESBL Confirm (Chrom. AmpC) Kit (EUCAST) Cefepime Cefepime + Clavulanate 100 ESBL New 98022 Rapid ESBL Screen Kit Cefotaxime + tazobactam + Indicator Cefotaxime + Indicator ESBL Screening and Confirmation of ESBL+AmpC REF no. Product Tests pr. kit Detection of: ESBL + AmpC Screen Kit 98008 Cefotaxime Cefotaxime + Clavulanate Cefotaxime + Cloxacillin Cefotaxime + Clavulanate + Cloxacilin ESBL + AmpC Total ESBL + AmpC Confirm Kit 98019 Cefotaxime + Cloxacillin Cefotaxime + Clavulanate Ceftazidime + Cloxacillin Ceftazidime + Clavulanate Cefotaxime + Cloxacillin + Clavulanate Ceftazidime + Cloxacillin + Clavulanate ESBL + AmpC 12-02-2014 Kits Product list Rosco Diagnostica A/S

Screening and Confirmation of Carbapenemases REF no. Product Tests pr. kit Detection of: 98021 Rapid CARB Screen Kit Imipenem + Indicator (CARB) Diatabs CARB Negative Control Diatabs Carbapenemases Enterobacteriaceæ P. aeruginosa 98006 KPC and MBL Confirm Kit (EUCAST) Meropenem Meropenem + Dipicolinic Acid Meropenem + Phenylboronic Acid Meropenem + Cloxacillin Carbapenemases Enterobacteriaceae 68912 Triple disk, for detection of KPC + MBL Meropenem + Phenylboronic + Dipicolinic acid Carbapenemases KPC, MBL and OXA-48 Confirm Kit 98015 Meropenem Meropenem + Dipicolinic acid Meropenem + Cloxacillin Meropenem + Phenylboronic acid Temocillin Carbapenemases Enterobacteriaceae KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit 98020 Meropenem Meropenem + Phenylboronic acid Meropenem + Cloxacillin High Imipenem Dipicolinic acid Carbapenemases P. aeruginosa/acinetobacter Total MBL Confirm kit 98016 Imipenem Imipenem + EDTA Imipenem + Dipicolinic acid Meropenem Dipicolinic acid MBL all species New 98023 OXA-48+CARB Screen kit (30-60 min) Imipenem + Brthymol Blue Ertapenem + Brthymol Blue Negative Control Blue Carbapenemases All species Lysis buffer Not needed Confirmation of AmpC s 12-02-2014 Kits Product list Rosco Diagnostica A/S

REF no. Product Tests pr. kit Detection of: AmpC Confirm Kit 98007 Cefotaxime Cefotaxime + Cloxacillin Ceftazidime Ceftazidime + Cloxacillin AmpC Other Kits REF no. Product Tests pr. kit Detection of: 98017 Detection of hgisa,gisa,vre,daptomycin resistance Vancomycin Teicoplanin Daptomycin Staphylococci Enterococci 98018 Detection of COLISTIN resistance in Enterobacteriaceae, P. aeruginosa and Acinetobacter COLISTIN Prediffusion 100 MDR Gram negatives Urin Kit Privat Praksis 98009 Ampicillin Ciprofloxacin Mecillinam Nitrofurantoin Sulphonamide Trimethoprim Beta-Glucuronidase Susceptibility testing urines All products are CE marked according to the European Directive 98/79/EC for In Vitro Diagnostic Medical Devices. Detection of resistance mechanisms User s Guide The latest version of detection of resistance mechanisms User s Guide is downloadable from our website. Minimum orders for kits are 1 package. 12-02-2014 Kits Product list Rosco Diagnostica A/S

AmpC Confirm Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation 4 cartridges, formulated for maximum stability, each containing approximately tablets: Cefotaxime 30 µg, coded CTX30 Cefotaxime 30 µg + Cloxacillin, coded CTXCX Ceftazidime 30 µg, coded CAZ30 Ceftazidime 30 µg + Cloxacillin, coded CAZCX Quality Control As positive Q. C. stains the following may be used: Enterobacter cloacae NCTC 13406, AmpC positive Enterobacter cloacae ATCC BAA 1143, Amp C positive E. coli ATCC 25922 is a negative Q. C. stain All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL,AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, 724-732, 2012. Edquist P et al : Phenotypic detection of plasmid-acquired AmpC in E. coli- evaluation of screening criteria and performance of 2 commercial methods for the phenotypic confirmation of AmpC production Eur J Clin Microbiol Infect Dis 32,1205-1210, 2013. AmpC Cefotaxime 30 µg Ceftazidime30 µg CTX30 CAZ30 CTXCX 5mm - AmpC CAZCX - 5mm AmpC Confirm Kit Ref. 98007 Okt. 2013

Susceptibility testing of Antifungals REF NO. PRODUCT 98967 Mueller Hinton agar BBL - II ANTIFUNGAL AGENTS REF NO. PRODUCT CODE POTENCY STORE 2-8 81012N Amphotericin B AMPHO 10 n 82412N Caspofungin CASP5 5 n 81112N Ciclopirox CICLO 81212N Clotrimazole CTRIM 10 81312N Econazole ECONZ 10 82512N Fluconazole FLUCZ 25 81512N Fluorocytosine FLU.1 1 81812N Itraconazole ITRAC 10 81912N Ketoconazole KETOC 15 82012N Miconazole MICOZ 10 82212N Nystatin NYSTA 82612N Posaconazole POSAC 5 87412N Terbinafine TERBI 30 82312N Voriconazole VOR.1 1 PACKAGING The cartridges contain tablets. Packed in boxes containing 1 x 5 cartridges = 2 tablets. STORAGE Our product have 2 years to 5 years of expire date. When cartridge are opened and placed in a dispenser: Cartridges to be kept at room temperature: To be used within the next 12 months. Cartridges to be kept at 2-8 : To be used within 2 months. Product list 2013 Neo-Sensitabs Susceptibility Testing Potencies according to EUCAST and CLSI Okt. 2013

Detection of COLISTIN resistance in Enterobacteriaceae, P. aeruginosa and Acinetobacter Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The prediffusion method is very useful for testing high molecular antimicrobials. Content and formulation 2 cartridges of COLISTIN Prediffusion Neo-Sensitabs, formulated for maximum stability, each containing tablets. Totaling 100 tests Quality Control As Q. C. strains the following may be used: E. coli ATCC 25922 Ps. aeruginosa ATCC 27853. All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Boyen F et al: Disk prediffusion is a reliable method for testing Colistin susceptibility in porcine E. coli strains. Vet Microbiol 144,359-362, 2010. Nastro M et al Evaluation of the prediffusion method for Colistin in K. pneumonia. Rev Argent Microbiol 44, supl1, P40, 2012 (Spanish) COLISTIN Prediffusion Sensitive Intermediate Resistant Enterobacteriaceae 16 mm 15-12 mm < 12 mm Ps aeruginosa 16 mm 15-12 mm < 12 mm Acinetobacter spp. 20 mm 19-14 mm < 14 mm Detection of COLISTIN resistance in Enterobacteriaceae, P. aeruginosa and Acinetobacter Ref. 98018 Okt. 2013

Detection of hgisa, GISA, VRE and Daptomycin susceptibility Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The prediffusion method is very useful for testing high molecular antimicrobials. Content and formulation 3 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Vancomycin 30 µg, coded VAN30 Teicoplanin 30 µg, coded TEI30 Daptomycin 30 µg, coded DAP30 All products from Rosco Diagnostica A/S are Quality Control marked in compliance As Q. C. strains the following may be used: with the European Union Staph aureus ATCC 700698; hvisa and Daptomycin susceptible directive 98/79/EC for Staph aureus AST 403, GISA and Daptomycin susceptible In Vitro Diagnostic Medical Enterococcus faecalis ATCC 51299, Van B. Staph aureus AST 408, GISA and Daptomycin resistant Devices. References Nielsen SV,Casals JB: Detection of decreased susceptibility to glycopeptides in S. aureus using tablet(disc) prediffusion.presented at ECCMID 2005. Koeth L et al: Multisite evaluation of the Daptomycin Neo-Sensitab prediffusion method against 20 S. aureus.presentation P-1065, ECCMID 2011. Vancomycin 30 ug Teicoplanin 30 ug Daptomycin 30 ug hgisa < 20 mm or < 20 mm GISA < 20 mm and < 20 mm < 5mm VRE Van A no Zone No zone Van B < 16mm(hazy) > 20 mm Van C < 12 mm (sharp) > 20 mm Daptomycin resistance Staphylococci < 20 mm Enterococci no zone Detection of hgisa, GISA, VRE and Daptomycin susceptibility Ref. 98017 Okt. 2013

ESBL + AmpC Screen Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation 4 cartridges, each containing approximately tablets, formulated for maximum stability: Cefotaxime 30 µg, coded CTX30 Cefotaxime 30 µg + Clavulanate, coded CTX+C Cefotaxime 30 µg + Cloxacillin, coded CTXCX Cefotaxime 30 µg + Clavulanate + Cloxacillin, coded CTXCC Quality Control As positive Q. C strains the following may be used: Enterobacter cloacae NCTC 13406, Amp C positive Enterobacter cloacae ATCC BAA 1143, Amp C positive Klebs. pneumoniae ATCC 700603 ESBL positive All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL,AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, 724-732, 2012. Edquist P et al : Phenotypic detection of plasmid-acquired AmpC in E. coli- evaluation of screening criteria and performance of 2 commercial methods for the phenotypic confirmation of AmpC production Eur J Clin Microbiol Infect Dis 32,1205-1210, 2013. ESβL AmpC ESβL + AmpC CTX+C or B CTXCC D CTXCX or C CTXCC D CTX+C and B CTXCC D Cefotaxime CTX30 A 5 mm - 5 mm - <5 mm (AmpC) - Cefotaxime + Clavulanate CTX+C B - <5 mm - 5 mm - 5 mm (AmpC) Cefotaxime + Cloxacillin CTXCX C - 5 mm - <5 mm - 5 mm (ESBL) ESBL + AmpC Screen Kit Ref. 98008 Okt. 2013

Total ESBL + AmpC Confirm Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Content and formulation 6 cartridges of tablets, formulated for maximum stability, each containing tablets: Cefotaxime + Cloxacillin, coded CTXCX Cefotaxime + Clavulanate, coded CTX+C Ceftazidime + Cloxacillin, coded CAZCX Ceftazidime + Clavulanate, coded CAZ+C Cefotaxime + Cloxacillin + Clavulanate, coded CTXCC Ceftazidime + Cloxacillin + Clavulanate, coded CAZCC Quality Control As positive Q. C. stains the following may be used: Enterobacter cloacae NCTC 13406, AmpC positive Klebs. pneumoniae ATCC 700603, ESBL positive Enterobacter cloacae ATCC BAA-1143 AmpC positive All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESB, AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, 724-732, 2012. Edquist P et al: Phenotypic detection of plasmid-acquired AmpC in E. coli- evaluation of screening criteria and performance of 2 commercial methods for the phenotypic confirmation of AmpC production Eur J Clin Microbiol Infect Dis 32,1205-1210, 2013. Enterobacteriaceae Cefotaxime + Cloxacillin + Clavulanate CTXCC Ceftazidime + Cloxacillin + Clavulanate CAZCC Cefotaxime + Cloxacillin >= 5 mm and/or - ESBL Ceftazidime + Cloxacillin >= 5 mm AmpC Cefotaxime + Clavulanate >= 5 mm and/or - Ceftazidime + Clavulanate >= 5 mm- Cefotaxime + Cloxacillin >= 5 mm and ESBL + AmpC Cefotaxime + Clav Ceftazidime + Cloxacillin >= 5 mm >= 5 mm and Ceftazidime + Clav >= 5 mm Total ESBL + AmpC Confirm Kit Ref. 98019 Okt. 2013

ESBL Confirm Kits Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation ESBL Confirm (acc. to CLSI/EUCAST) Kit (98011) Comprises one cartridge ( tests) each of the following Cefotaxime 30 µg Cefotaxime 30 µg + Clavulanate Ceftazidime 30 µg Ceftazidime 30 µg + Clavulanate Testing of Enterobacteriaceae Group 1 (without chromosomal AmpC) according to CLSI/EUCAST. ESBL Confirm (Chrom. AmpC) Kit (98012) It comprises two cartridges (100 tests) each of the following: Cefepime 30 µg Cefepime 30 µg + Clavulanate Testing of Enterobacteriaceae Group 2 (possessing chromosomal AmpC) according to EUCAST. Total ESBL Confirm Kit (98014) Comprises one cartridge ( tests) each of the following: Cefotaxime 30 µg Cefotaxime 30 µg + Clavulanate Ceftazidime 30 µg Ceftazidime 30 µg + Clavulanate Cefepime 30 µg Cefepime 30 µg + Clavulanate Testing of any kind of Enterobacteriaceae, including chromosomal AmpC producers. All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Quality Control As positive Q.C. strains the following may be used: Klebsiella pneumoniae ATCC 700603,ESBL positive,(except cefepime) Enterobacter cloacae NCTC 13464, ESBL positive (use Cefepime and FEP+C) References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL, AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, 724-732, 2012. Reuland E.A.et al: High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints Clin Microbiol Infect 19, 542-549, 2012. ESBL Confirm kits Ref. 98011 98012 98014 Okt. 2013

KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The kit is intended for detection of the carbapenemases; KPC and MBL in Pseudomonas aeruginosa and MBL in Acinetobacter spp. Content and formulation 5 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Meropenem 10 µg, coded MRP10 Meropenem 10 µg + Phenylboronic Acid (KPC and AmpC inhibitor), coded MRPBO Meropenem 10 µg + Cloxacillin High (AmpC inhibitor), coded MPCXH All products from Rosco Imipenem 10 µg, coded IMI10 Diagnostica A/S are Dipicolinic acid (DPA) marked in compliance Quality Control As positive Q. C. strains the following may be used: P. aeruginosa ATTC 10145/CCUG 59626, MBL positive K. pneumoniae CCUG 58547, MBL positive K. pneumoniae NCTC 13439, MBL positive K. pneumoniae CCUG 56233, KPC positive K. pneumoniae NCTC 13438, KPC positive References Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Dongeun Yong et al: Evaluation of double-disk potentiation tests using Dipicolinic acid for detection of MBL-producing Pseudomonas spp and Acinetobacter spp. J. Clin. Microbiol, 3227-3232, 2012. Miriagou V et al: Detecting VIM-1 production in P. mirabilis by an Imipenem-Dipicolinic acid double disk synergy test: J. Clin Microbiol 48,667-668, 2010 KPC MβL Mc Conkey agar Meropenem + Phenylboronic MRPBO Meropenem + Cloxacillin High MPCXH Meropenem 10 µg 4mm and < 3 mm P. aeruginosa MRP10 Meropenem + Cloxacillin High 4 mm MPCXH P. aeruginosa Imipenem - - Synergism Acinetobacter 10 µg IMI10 - - Synergism DPA KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit Ref. 98020 Okt. 2013

KPC/Metallo-β-Lactamase Confirm Kit KPC/MBL and OXA-48 Confirm Kit Meropenem+Boronic Acid+Dipicolinic Acid Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The kit is intended for detection of the carbapenemases; KPC, MBL and OXA-48 in Enterobacteriaceae Content and formulation 4 or 5 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Meropenem 10 µg, coded MRP10 Meropenem 10 µg + Phenylboronic Acid (KPC and AmpC inhibitor), coded MRPBO Meropenem 10 µg + Cloxacillin (AmpC inhibitor), coded MRPCX Meropenem 10 µg + Dipicolinic acid (Metallo-β-Lactamase inhibitor), coded MRPDP Temocillin 30 ug (only in the OXA-48 Confirm kit 98015) Quality Control As positive Q. C. strains the following may be used: Klebs. pneumoniae NCTC 13438, KPC positive Klebs. pneumoniae NCTC 13439, MBL positive Klebs. pneumoniae ATCC BAA-1705, KPC positive Klebs. pneumoniae ATCC BAA-2146, MBL positive As negative Q.C strain the following may be used: Klebs. pneumoniae ATCC 700603 All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Giske CG et al: A sensitive and specific phenotypic assay for detection of MBL and KPC in K. pneumoniae with the use of meropenem disks supplemented with phenylboronic acid,dipicolinic acid and cloxacillin.clin Microbiol Infect 17,552-556,2011. Ambrettii S et al: Evaluation of phenotypic and genotypic approaches for the detection of Class A and Class B carbapenemases in Enterobacteriaceae.Microbial Drug Res 19,212-215, 2013. Miriagou V et al: Combined disk methods for the detection of KPC and/or VIM positive K. pneumoniae: improving reliability for the double carbapenemase producers.clin Microbiol Infect E412-E415,2013 Giakkoupi P et al: Evaluation of the modified KPC+MBL Confirm kit for the phenotypic detection of Class A and B carbapenemases in K. pneumoniae isolates. Presented at the ECCMID 2012. KPC/Metallo-β-Lactamase Confirm Kit Ref. 98006 KPC/MBL and OXA-48 Confirm Kit Ref. 98015 Meropenem+Boronic Acid+Dipicolinic Acid Ref. 68912 Oct. 2013

AmpC + porin loss ESBL + porin loss (a) KPC MβL OXA-48 and similars OXA-48 + ESBL (a) Meropenem 10 µg MRP10 Meropenem 10 µg MRP10 Meropenem 10 µg MRP10 Meropenem + Cloxacillin (MRPCX) Meropenem 10 µg MRP10 Meropenem 10 ug MRP10 Meropenem 10 ug MRP10 Meropenem + Phenylboronic MRPBO 4mm and Meropenem + DPA MRPDP Meropenem + Cloxacillin MRPCX Temocilin 30 µg 3 mm 5mm 12mm 3 mm 3 mm 3 mm 12mm 4mm 3 mm 3 mm Variable 4mm - - - < 4mm 5mm 3 mm Variable 3 mm 3 mm 3 mm 3 mm 3 mm 3 mm No zone of inhibition No zone of inhibition Triple Disk MER + DPA + BO double inhibitor KPC MRPDP 4 mm MBL MRPBO 4 mm KPC + MBL MRPDP MRPBO 4 mm and 4 mm KPC/Metallo-β-Lactamase Confirm Kit Ref. 98006 KPC/MBL and OXA-48 Confirm Kit Ref. 98015 Meropenem+Boronic Acid+Dipicolinic Acid Ref. 68912 Oct. 2013

Rapid CARB Screen Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro screening of carbapenemase producing bacteria. The method is valid for Enterobacteriaceae and Pseudomonas aeruginosa. Content and formulation Two vials with 6 mm tablets; Imipenem + Indicator (CARB), formulated for maximum stability, each containing 25 tablets equivalent to a total of tests: One vial with 6 mm. tablets: CARB Negative Control Diatabs, tablets. Interpretation of results A change of color from red to yellow indicates a positive reaction, indicating that the test strain possesses a carbapenemase. If the reaction is positive after 30 minutes or 1 hour, it is not necessary to incubate further. In most cases, a carbapenemase is detected in 30 min. Please notice: Some Enterobacteriaceae producing OXA 48 (or similar), showing MIC s for Imipenem <= 0.5 µg / ml may show a negative result with Rapid CARB Screen Kit. These isolates should be reported as susceptible to Imipenem/meropenem according to CLSI and EUCAST recommendations. Quality Control DIATABS POSITIVE NEGATIVE Imipenem + Indicator (CARB) Klebsiella pneumoniae BAA 1705 E. coli ATCC 25922 References Nordmann P et al. Rapid detection of carbapenemase producing Enterobacteriaceae. Emerg. Infect. Dis. 18, 13-17, 2012. Nordmann P et al. Rapid detection of carbapenemase production in Pseudomonas. Presentation CI-078, ICAAC, 2012. Tijet N et al:" Evaluation of the Carba NP Test for rapid detection of carbapenemase-producing Enterobacteriaceae and Ps aeruginosa." Antimicr Ag. Chemother 57,4578-4580, 2013. All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Rapid CARB Ref. 98021 Okt. 2013

Rapid ESBL Screen Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro screening of ESBL producing bacteria. The method is valid for Enterobacteriaceae. Content and formulation One vial with 6 mm tablets; Cefotaxime + Indicator (ESBL) Diatabs, formulated for maximum stability, each containing tablets equivalent to a total of tests. One vial with 6 mm. tablets: Cefotaxime + Tazobactam + Indicator (ESBL) Diatabs, tablets. Interpretation of results A change of color from red to yellow indicates a positive reaction. If the reaction is positive after 30 minutes or 1 hour, it is not necessary to incubate further. The tube must be incubated for no more than 2 hours, because positive reactions may fade out. Quality Control DIATABS Positive Negative Enterobacter cloacae NCTC 13464 E. coli ATCC 25922 Cefotaxime + Indicator Yellow Red Cefotaxime + Tazo + indicator Red Red References Nordmann P et al. Rapid detection of Extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J.Clin Microbiol., 3016-3022, 2012. All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Rapid ESBL Ref. 98022 Jan. 2014

Total Metallo-β-Lactamase Confirm Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation 5 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Meropenem 10 µg, coded MRP10 Dipicolinic acid, coded DPA Imipenem 10 µg, coded IMI10 All products from Rosco Imipenem 10 µg + DPA, coded IM+DP Diagnostica A/S are Imipenem 10 µg + EDTA, coded IM10E marked in compliance Quality Control As positive Q. C. stains the following may be used: Klebs. pneumoniae NCTC 13438, MBL positive Klebs. pneumoniae ATCC BAA-2146, MBL positive References with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Dongeun Yong et al: Evaluation of double-disk potentiation tests using Dipicolinic acid for detection of MBL-producing Pseudomonas spp and Acinetobacter spp. J. Clin. Microbiol, 3227-3232, 2012. Miriagou V et al: Detecting VIM-1 production in P. mirabilis by an Imipenem-Dipicolinic acid double disk synergy test: J. Clin Microbiol 48,667-668, 2010 Enterobacteriaceae MBL MBL Meropenem 10 µg MRP10 Imipenem 10 µg IMI10 DPA Imipenem + DPA IM+DP Imipenem + EDTA IM10E Synergism - - Synergism 5 mm 10 mm Pseudomonas aeruginosa. Mc Conkey agar Acinetobacter spp. Mc Conkey agar MBL MBL Imipenem 10 µg IMI10 Meropenem 10 µg MRP10 DPA Synergism Imipenem + DPA IM+DP 5 mm or Imipenem + EDTA IM10E 10 mm Synergism - - Total Metallo-β-Lactamase Confirm Ref. 98016 Okt. 2013

Okt.2013 Neo-Sensitabs - a Unique Solution Unique characteristics ensure that NEO-SENSITABS are ideal for use in the clinic Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Susceptibility testing with NEO-SENSITABS practice is performed according to CLSI and EUCAST guidelines. For the Neo-Sensitabs marked 2-8 C the following applies: Unopened cartridges in stock Store in a refrigerator at 2-8 C Cartridges opened and in use Use and store at room temperature within 2 months. For all other Neo-Sensitabs: Unopened cartridges in stock Cartridges opened and in use Rosco Dispensers 7 cartridges round Petri dishes of 9 cm diameter 12 cartridges round Petri dishes of 14-15 cm diameter 16 cartridges square Petri dishes of 12 x 12 cm Store at room temperature Use and store at room temperature within 12 months. REF. No. 97105 All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. For convenient and accurate dispensing of one or a few tablets at a time, use this handy single cartridge dispenser. References Justesen U.S et al:" Comparison of Rosco Neo-Sensitabs with Oxoid paper disks in EUCAST disk diffusion antimicrobial susceptibility testing on Mueller-Hinton agar".eur J Clin Microbiol Infect Dis 32,621-625, 2013. Rosco User s Guides The User s Guide contains comprehensive data and information on several subjects. NEO-SENSITABS EUCAST-and CLSI potency NEO-SENSITABS DETECTION OF RESISTANCE MECHANISMS REGRESSION LINES NEO-SENSITABS The contents are continuously updated the latest edition is from 2013. Freely available on the Rosco website can be read or downloaded. Rosco Diagnostica A/S also produces Diatabs a range of enzymatic tests for rapid identification and differentiation of bacterial species.